JPH03178331A - Microemulsion composition - Google Patents
Microemulsion compositionInfo
- Publication number
- JPH03178331A JPH03178331A JP31692589A JP31692589A JPH03178331A JP H03178331 A JPH03178331 A JP H03178331A JP 31692589 A JP31692589 A JP 31692589A JP 31692589 A JP31692589 A JP 31692589A JP H03178331 A JPH03178331 A JP H03178331A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- poe
- emulsion
- nonionic surfactant
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000004530 micro-emulsion Substances 0.000 title abstract 3
- 239000000839 emulsion Substances 0.000 claims abstract description 36
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 15
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 14
- 239000011709 vitamin E Substances 0.000 claims abstract description 14
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 14
- 229940046009 vitamin E Drugs 0.000 claims abstract description 14
- 239000002245 particle Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 7
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 27
- -1 fatty acid esters Chemical class 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 3
- 239000004147 Sorbitan trioleate Substances 0.000 description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000019337 sorbitan trioleate Nutrition 0.000 description 3
- 229960000391 sorbitan trioleate Drugs 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- TXYKVMGAIGVXFY-UHFFFAOYSA-N 1-undecoxyundecane Chemical compound CCCCCCCCCCCOCCCCCCCCCCC TXYKVMGAIGVXFY-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、後記特定の比率の液状の油性物質。[Detailed description of the invention] [Industrial application field] The present invention relates to a liquid oily substance having a specific ratio described below.
特定の非イオン性界面活性剤、ビタミンE又はビタミン
E誘導体、水を含む予備エマルションを衝突させること
により調製される微細化エマルション組成物に関し、さ
らに詳しくは、化粧品、医薬品などの分野に利用できる
、皮膚安全性、官能特性、保存安定性にすぐれた微細化
エマルションキ■酸物に関する。Regarding a finely divided emulsion composition prepared by colliding a pre-emulsion containing a specific nonionic surfactant, vitamin E or a vitamin E derivative, and water, more specifically, it can be used in the fields of cosmetics, pharmaceuticals, etc. This invention relates to a micronized emulsion compound with excellent skin safety, sensory properties, and storage stability.
〔従来の技術及び発明が解決しようとする課題〕従来知
られている微細化エマルションの開発において、乳化粒
子を微細化し、透明な組成物を得るには、一般に界面活
性剤が多くなり、例えばこれを化粧料として応用する場
合には、界面活性剤が多くなる為に官能特性、皮膚安全
性の低下、などの問題点があった。[Prior art and problems to be solved by the invention] In the development of conventionally known fine emulsions, in order to make the emulsion particles fine and obtain a transparent composition, it is generally necessary to use a large amount of surfactant. When applied as cosmetics, there are problems such as a decrease in organoleptic properties and skin safety due to the large amount of surfactant.
例えば、一般の透明化粧水を例にとると、配合される油
性酸分に対し、必要とされる界面活性剤は、その5〜2
0(@量である。For example, if we take a general transparent lotion as an example, the amount of surfactant required for the oily acid content is 5 to 2.
0 (@ quantity.
しかし、特開昭52−151676号公報、特公昭59
−15005号公報に記載されている乳化分散方法を用
いれば、少量の界面活性剤で多贋の油性成分を含有する
微細化エマルションの調製が可能である。これらに記載
されている乳化分散方法は、公知の高圧乳化法であり、
乳化物を少なくとも一つのノズルより噴射せしめて、該
乳化物同士を衝突させるか、又は〃抜孔化物を器壁に衝
突させることにより、微細化するものである。このよう
な乳化分散方法を応用した6 2Nとしては、例えば、
マイクロフルイダイザー(Micro−fluidic
s社製)が挙げられる。これにより、例えば、多量の油
性成分を含有する感触の良好な皮膚安全性の高い透明化
粧水の調製が可能となった。However, Japanese Patent Application Publication No. 52-151676,
By using the emulsification and dispersion method described in Japanese Patent Publication No. 15005, it is possible to prepare a fine emulsion containing many fake oily components using a small amount of surfactant. The emulsification and dispersion method described in these is a known high-pressure emulsification method,
The emulsions are injected from at least one nozzle and the emulsions are made to collide with each other, or the perforated material is made to collide with the wall of the vessel, thereby making it fine. As 62N to which such an emulsification dispersion method is applied, for example,
Micro-fluidizer
(manufactured by S company). This has made it possible, for example, to prepare a transparent lotion that contains a large amount of oily ingredients, has a good feel, and is highly safe for the skin.
ところが、こうして得た微細化エマルションは必ずしも
安定性が良いとは言えず、加熱あるいは経時で粒子が合
一したり、分離し微細化されている状態を維持できない
という問題点を有している。However, the micronized emulsion thus obtained is not necessarily stable, and has the problem that the particles coalesce or separate when heated or over time, making it impossible to maintain the micronized state.
例えば、油性成分に対し適正な非イオン性界面活性剤を
組み合わせて、得られた予備エマルションを上述乳化分
散方法により処理することにより、容易に透明あるいは
半透明な微細化エマルションを!Il製することができ
る。また、油性成分量に対し、非イオン性界面活性剤は
、0.5〜2.0倍量で充分である。しかし、その微細
化エマルションは45℃で放置することにより、l〜2
週間、早いものでは翌日で白濁あるいは分離してしまう
。For example, by combining an appropriate nonionic surfactant with an oily component and treating the resulting pre-emulsion using the emulsification and dispersion method described above, you can easily create a transparent or translucent fine emulsion! It can be made from Il. Furthermore, it is sufficient to use the nonionic surfactant in an amount of 0.5 to 2.0 times the amount of the oily component. However, by leaving the fine emulsion at 45°C,
Weeks, or as early as the next day, it becomes cloudy or separates.
すなわち、この微細化エマルションは、官能特性、皮膚
安全性には優れているが、保存安定性が悪いという問題
点を有している。That is, although this finely divided emulsion has excellent organoleptic properties and skin safety, it has the problem of poor storage stability.
前記乳化分散方法を用い、少量の界面活性剤で、多量の
油性成分を含有した皮膚安全性、官能特性に優れ、そし
て保存安定性にも優れた微細化エマルションを調製すべ
り、鋭意研究を重ねた結果、通常の微細化エマルション
に使用される室温で液状の油性物質と非イオン性界面活
性剤を組み合わせた乳化四組酸物に乳化活性助剤として
所定星のビタミンE、又はビタミンE誘導体を配合する
ことにより、その微細化エマルションは、驚くべきこと
にこれらを配合しない微細化エマルションに比べ保存安
定性が著しく向上することを見い出し、本発明を完成す
るに至ったのである。Using the above-mentioned emulsification and dispersion method, we prepared a finely divided emulsion containing a large amount of oily components with a small amount of surfactant, which has excellent skin safety, sensory properties, and storage stability. As a result, vitamin E or a vitamin E derivative of a specified star is added as an emulsification activation aid to the emulsified tetraacid acid, which is a combination of an oily substance that is liquid at room temperature and a nonionic surfactant, which is used in ordinary fine emulsions. By doing so, it was surprisingly discovered that the storage stability of the finely divided emulsion was significantly improved compared to a finely divided emulsion that did not contain these ingredients, and the present invention was completed.
本発明は、(al室温にて液状の油性物質の少なくとも
一種、とibl o L B値がマ、 O−16,0の
範囲である非イオン性界面活性剤の少なくとも一種、と
fclビタミンE又はビタミンE誘導体の少なくとも一
種、とfdl水を含有し、かつ前記+a) : (bl
: iclの重量比が!(0,5〜5.0) :
(0,01〜0.5)の範囲である予備エマルション
同士を衝突させる又は該予備エマルションを壁に衝突さ
せることにより得られる、平均粒径が10〜200nm
であることを特徴とする微細化エマルションm酸物であ
る。The present invention comprises (al) at least one oily substance that is liquid at room temperature, at least one nonionic surfactant having an ibl o LB value in the range of O-16.0, and fcl vitamin E or containing at least one vitamin E derivative and FDL water, and the above +a): (bl
: The weight ratio of ICL! (0,5~5.0):
(0.01 to 0.5), with an average particle size of 10 to 200 nm, obtained by colliding preemulsions with each other or colliding the preemulsions with a wall.
It is a micronized emulsion m-acid characterized by the following.
以下本発明の構成について詳述する。The configuration of the present invention will be explained in detail below.
本発明に用いるl夜状の油性物質とは、常温下で液状を
里する油類であって、例えば流動パラフィン、スクワラ
ン、液状の合成エステル2由頚(イソプロピルミリステ
ート、イソプロピルパルミテート、ミリスチン酸オクチ
ルドデシル等)、植物油(オリーブ油、大豆油、米ぬか
油、綿実柚等)メチルフェニルポリシロキサン等を挙げ
ることができる。但し、これらに限定されるものではな
い。The oily substances used in the present invention are oils that are liquid at room temperature, such as liquid paraffin, squalane, and liquid synthetic esters (isopropyl myristate, isopropyl palmitate, myristic acid). octyldodecyl, etc.), vegetable oils (olive oil, soybean oil, rice bran oil, cottonseed yuzu, etc.), methylphenylpolysiloxane, and the like. However, it is not limited to these.
液状の油性物質類は、単独または2種以上組み合わせて
使用される。Liquid oily substances may be used alone or in combination of two or more.
本発明において用いられる非イオン性界面活性剤は、通
常、化粧品などの原料として用いられるものであり、特
に限定はされない。例えば、ポリオキシエチレン(以下
、POEという)ソルビタンモノオレエート、POEソ
ルビタンモノステアレート、POEソルビタントリオレ
エート等のPOEソルビタン脂肪酸エステル類、POE
ソルビットモノオレエート、POEソルビットペンタオ
レエート、POEソルビットモノステアレート等のPO
Eソルビット脂肪酸エステルti、POEグリセリンモ
ノステアレート、POEグリセリンモノイソステアレー
ト、POEグリセリントリイソステアレート等のPOE
グリセリン脂肪酸エステル類、グリセリルモノステアレ
ート、グリセリルモノイソステアレート等のグリセリン
脂肪酸エステル’1.POEモノオレエー1−、POE
ジステアレート、POEジオレエート等のPOE脂肪酸
エステル類、POEオレイルエーテル、POEステアリ
ルエーテル、POEベヘニルエーテル。The nonionic surfactant used in the present invention is normally used as a raw material for cosmetics and the like, and is not particularly limited. For example, POE sorbitan fatty acid esters such as polyoxyethylene (hereinafter referred to as POE) sorbitan monooleate, POE sorbitan monostearate, POE sorbitan trioleate, POE
PO such as sorbitol monooleate, POE sorbitol pentaoleate, POE sorbitol monostearate, etc.
POE such as E sorbitol fatty acid ester ti, POE glycerin monostearate, POE glycerin monoisostearate, POE glycerin triisostearate, etc.
Glycerin fatty acid esters such as glycerin fatty acid esters, glyceryl monostearate, glyceryl monoisostearate, etc.'1. POE monooleate 1-, POE
POE fatty acid esters such as distearate and POE dioleate, POE oleyl ether, POE stearyl ether, and POE behenyl ether.
POE2.−オクチルドデシルエーテル、POE2ヘキ
シルデシルエーテル、POE2−へブチルウンデシルエ
ーテル、POE2−デシルテトラデシルエーテル、PO
E2−デシルペンタデシルエーテル、POEコレスタノ
ールエーテル等のPOEアルキルエーテル類、POEノ
ニルフェニルエーテル等のPOEアルキルフェニルエー
テル類、POE−POPブロックコポリマー類。POE2. -Octyldodecyl ether, POE2-hexyldecyl ether, POE2-hebutyl undecyl ether, POE2-decyltetradecyl ether, PO
POE alkyl ethers such as E2-decylpentadecyl ether and POE cholestanol ether, POE alkyl phenyl ethers such as POE nonylphenyl ether, and POE-POP block copolymers.
POE・POPセチルエーテル、POE−POE2−デ
シルテトラデシルエーテル、POE・POP水添ラノリ
ン等のPOE −POPアルキルエーテル類、POEヒ
マシ油等のPOEヒマシ油または硬化ヒマシ油誘導体、
POEソルビットミツロウ等のpoEsツロウ・ラノリ
ン誘導体、シラ糖オレイン酸モノエステル等のシュガー
エステル類、ポリグリセリンモノアルキルエステルおよ
びモノアルキルエーテル類等が挙げられる。POE-POP alkyl ethers such as POE/POP cetyl ether, POE-POE2-decyltetradecyl ether, POE/POP hydrogenated lanolin, POE castor oil or hydrogenated castor oil derivatives such as POE castor oil,
Examples include poEs wax and lanolin derivatives such as POE sorbitol beeswax, sugar esters such as sila sugar oleic acid monoester, polyglycerin monoalkyl esters and monoalkyl ethers.
これらの非イオン性界面活性剤のうち、HLB値が7.
0〜16.0の範囲のもの1種または2種以上の組合せ
において用いられる。Among these nonionic surfactants, those with an HLB value of 7.
One type or a combination of two or more types in the range of 0 to 16.0 may be used.
これら液状の油性物質とその乳化分散に適した非イオン
性界面活性剤の組み合わせとしては、例えば次の様なも
のが挙げられる。Examples of combinations of these liquid oily substances and nonionic surfactants suitable for emulsifying and dispersing them include the following.
液状の油性物質 非イオン性界面活性剤流動
パラフィン
ポリオキシエチレン
ソルビタンモノステアレート
(20E、 ○、)
ポリオキシエチレン
ソルビタントリステアレート
(20E、O,)
ポリオキシエチレン
グリセリンモノステアレート
(5E、O,)
スクワラン
ポリオキシエチレン
ソルビタントリオレエート
(20E、O,)
ポリオキシエチレン
ソルビタンモノオレエート
(6E、O,)
ポリオキシエチレン
モノステアレート
(IOE、O−)
ミリスチン酸
オクチルドデシル
ポリオキシエチレン
モノラウレート
(10E、O,)
ポリオキシエチレン
ソルビットテトラオレエート
(40E、 O,y
ポリオキシエチレン
セチルエーテル
(IOE、O,)
オリーブ油
ポリオキシエチレン
オレイルエーテル
(7E、 ○、〉
ポリオキシエチレン
ベヘニルエーテル
(10E、O,)
ポリオキシエチレン
硬化ヒマシ油
(20E、O,)
メチルフェニル
ポリシロキサン
ポリオキシエチレン
ソルビタントリオレエート
(20E、O,)
ポリオキシエチレン
ソルビタンモノオレエート
(6E、O,)
ポリオキシエチレン
硬化ヒマシ油
(20E、Q、)
もちろん、これらの組み合わせに、限定されるものでは
ない。Liquid oily substance Nonionic surfactant Liquid paraffin Polyoxyethylene sorbitan monostearate (20E, ○,) Polyoxyethylene sorbitan tristearate (20E, O,) Polyoxyethylene glycerin monostearate (5E, O, ) Squalane polyoxyethylene sorbitan trioleate (20E, O,) Polyoxyethylene sorbitan monooleate (6E, O,) Polyoxyethylene monostearate (IOE, O-) Octyldodecyl myristate polyoxyethylene monolaurate ( 10E, O,) Polyoxyethylene sorbittetraoleate (40E, O, y Polyoxyethylene cetyl ether (IOE, O,) Olive oil polyoxyethylene oleyl ether (7E, ○,) Polyoxyethylene behenyl ether (10E, O, ,) Polyoxyethylene hydrogenated castor oil (20E, O,) Methylphenylpolysiloxane polyoxyethylene sorbitan trioleate (20E, O,) Polyoxyethylene sorbitan monooleate (6E, O,) Polyoxyethylene hydrogenated castor oil ( 20E, Q,) Of course, the combination is not limited to these.
本発明に用いるビタミンE又はビタミンE誘導体は、公
知の物質であって、例えば、ビタミンEビラ1ンEアセ
テート、ビタミンE誘導体ネ−1・。The vitamin E or vitamin E derivative used in the present invention is a known substance, such as vitamin E virane-1 E acetate and vitamin E derivative ne-1.
ビタミンEサクシネート、ビタごンEリル−トビタ婁ン
Eオロテートなどが挙げられる。ビタミンEとは、α−
トコフェロール、β−トコフエロル、γ−1コフエロー
ル、 δ−)、コフェロール等あるいはこれらの混合
物を指す。Examples include vitamin E succinate, vitamin E lyl-tobital E orotate, and the like. Vitamin E is α-
Refers to tocopherol, β-tocopherol, γ-1 copherol, δ-), copherol, etc., or a mixture thereof.
本発明に於いては、これらのビタミンE又はビタミンE
m 6体の少なくとも一種が用いられる。In the present invention, these vitamin E or vitamin E
At least one of m6 bodies is used.
本発明に用いられる液状の油性物質の配合量であるが、
好ましくは0.1〜30重盪%である。また、非イオン
性界面活性剤の配合量は液状の油性物質との比率によっ
て定められ、その比率は10.5〜1:5であり、好ま
しくは1:1〜1:3である。非イオン性界面活性剤の
比率が1 : 0.5未満では、微細化エマルションが
生成せず、一方l:5を越えれば皮膚安全性、官能特性
に劣る。The amount of liquid oily substance used in the present invention is as follows:
Preferably it is 0.1 to 30% by weight. Further, the amount of the nonionic surfactant to be blended is determined by the ratio to the liquid oily substance, and the ratio is 10.5 to 1:5, preferably 1:1 to 1:3. If the ratio of nonionic surfactant is less than 1:0.5, no finely divided emulsion will be produced, while if it exceeds 1:5, the skin safety and sensory properties will be poor.
また、ビタミンE又はその誘導体の配合量についても、
同様に液状の油性物質との比率によって定められ、その
比率はl : 0.01〜1:O,Sであり、好ましく
は1:0.05〜1:0.2である。ビタミンE又はそ
の誘導体の比率が1=0.01未満では、本発明の目的
とする効果に充分でなく、方、1:0.5を越えても、
その増加分に見合った効果の向上は望めないものである
。Also, regarding the amount of vitamin E or its derivatives,
Similarly, it is determined by the ratio with the liquid oil substance, and the ratio is 1:0.01 to 1:O,S, preferably 1:0.05 to 1:0.2. If the ratio of vitamin E or its derivative is less than 1=0.01, it is not sufficient to achieve the desired effect of the present invention, but even if it exceeds 1:0.5,
It is not possible to expect an improvement in effectiveness commensurate with the increase.
このような比率で、通常の乳化方法により得た予備エマ
ルション同士を衝突させる又は該予備エマルションを壁
に衝突させて乳化粒子を微細化し、更には所望の平均粒
径とすべく、必要に応してこの微細化行程を繰り返して
微細化エマルションを得る0本発明に於ける微細化エマ
ルションの平均粒径は、10〜200nmであるが、こ
の範囲外たと外観が劣るため好ましくない。At such a ratio, the pre-emulsions obtained by a normal emulsification method are made to collide with each other or the pre-emulsions are made to collide with a wall to make the emulsified particles finer, and further, as necessary, to obtain a desired average particle size. The average grain size of the fine emulsion in the present invention is 10 to 200 nm, which is not preferable because the appearance will be poor if it is outside this range.
本発明に於いて、前述の予備エマルションを微細化させ
る手段としては例えばノズルによる噴射がある。この場
合、噴射圧力を例えば300〜1000kg/cm”
、 温度を5〜40℃の範囲で設定することによって、
前述所望の微細化エマルションを得ることができる。但
し、これは、装置機械により異なるものであって特に限
定されるものではない。In the present invention, as a means for making the above-mentioned preliminary emulsion fine, there is, for example, injection using a nozzle. In this case, the injection pressure should be set to 300 to 1000 kg/cm, for example.
, By setting the temperature in the range of 5 to 40℃,
The desired micronized emulsion described above can be obtained. However, this varies depending on the device and is not particularly limited.
本発明の微細化エマルション組成物の特徴は、従来の可
溶化系と比べて、はるかに少量の非イオン外界面活性剤
で大量の油性成分を配合できる、官能特性、皮膚安全性
に優れたかつ外観、保存安定性にも優れている点にある
。The fine emulsion composition of the present invention is characterized by being able to incorporate a large amount of oily ingredients with a much smaller amount of nonionic surfactant than conventional solubilized systems, and having excellent organoleptic properties and skin safety. It also has excellent appearance and storage stability.
尚、本発明の微細化エマルションには、上記必須成分の
他に、色素5香料、防腐剤、顔料、抗酸化剤、増粘剤、
保温剤、紫外線吸収剤、キレート剤、その他の油、界面
活性剤、活性助剤等が本発明の目的を達成する範囲内で
適宜配合することができる。In addition to the above-mentioned essential ingredients, the micronized emulsion of the present invention also contains five pigments, fragrances, preservatives, pigments, antioxidants, thickeners,
Heat insulating agents, ultraviolet absorbers, chelating agents, other oils, surfactants, active aids, and the like can be blended as appropriate within the range that achieves the object of the present invention.
本発明の微細化エマルソヨン組戒物は、例えばローショ
ン類、ヘアートニック、ヘアーオイル。The micronized emulsion composition of the present invention can be used, for example, in lotions, hair tonics, and hair oils.
クレンジングオイル、エアゾール製品、医薬用液剤等の
製品に使用することができる。It can be used in products such as cleansing oils, aerosol products, and pharmaceutical liquids.
以下、実施例及び比較例に基づいて本発明の詳細な説明
する。Hereinafter, the present invention will be described in detail based on Examples and Comparative Examples.
実施例に記載の皮膚安全性、官能特性、保存安定性に関
する試験法は、下記の通りである。The test methods for skin safety, sensory properties, and storage stability described in the Examples are as follows.
(1)皮膚安全性試験
被験者25名の前腕層側部の皮膚に、試料o、 o s
gを直径1.0 c mの円型のリント布のついたパ
ッチテスト用紳創膏を用いて24時間閉塞貼布した後、
下記の判定基準に従い、各試料について被験者25名の
皮膚の状態を評価判定した。(1) Skin safety test Samples o and o s were applied to the skin on the side of the forearm layer of 25 subjects.
g was applied for 24 hours as an occlusive patch using a circular lint cloth with a diameter of 1.0 cm.
The skin condition of 25 subjects was evaluated for each sample according to the following criteria.
判定結果は、絆創膏除去1時間後及び24時間後のうち
反応の強い方を採用し、評価が(±)以上の人の数で示
した。The evaluation results were determined based on the stronger reaction between 1 hour and 24 hours after removal of the bandage, and expressed as the number of people who rated (±) or higher.
判 定 基 準
(2)官能特性評価
被験者20名が試料をlO日間連用した後、試料の特性
を評価した。Judgment Criteria (2) Sensory Characteristics Evaluation After 20 test subjects used the sample for 10 days, the characteristics of the sample were evaluated.
試験結果は、各々「べとつき感またはぬめり感が無い」
、「皮膚とのなじみが良い」、「好ましい油性感である
」と回答した人数で示した。The test results were ``no sticky or slimy feeling''
, the number of people who answered that it blends well with the skin and that it has a desirable oily feel.
(3)保存安定性試験
試料を45℃の恒温室に2週間保存した後、試料の外観
を観察して、異常が認められない場合(外観が透明ある
いは半透明である)は良好とし、異常が認められる場合
(油が分離した場合、白濁した場合等)は不良とした。(3) Storage stability test After storing the sample in a constant temperature room at 45℃ for two weeks, observe the appearance of the sample. If no abnormality is observed (the appearance is transparent or translucent), it is considered good. If this was observed (oil separated, cloudy, etc.), it was judged as defective.
また、調製時にすでに白濁していたものは「−」とした
。In addition, those that were already cloudy at the time of preparation were marked as "-".
(4)平均粒径の測定
光子相関分光法を応用した、粒度分布分析装置サブミク
ロンサイザーB1−90 (BROOK−HAVEN
INsTRUMENTs C0R−PO[?ATI
ON製)を用い、調製直後の平均粒径を測定した。(4) Measurement of average particle size Particle size distribution analyzer submicron sizer B1-90 (BROOK-HAVEN) applying photon correlation spectroscopy
INsTRUMENTs C0R-PO[? ATI
(manufactured by ON), the average particle diameter was measured immediately after preparation.
実施例1〜11.比較例1〜53!l明化粧水下記の組
成に従って透明化粧水を調製し、前述諸試験を実施した
。その結果を第1表に示した。Examples 1-11. Comparative Examples 1 to 53! A transparent lotion was prepared according to the composition shown below, and the various tests described above were conducted. The results are shown in Table 1.
(1)
&ll戒
(2)調製法
(A)成分に(C)成分を〃室温または加塩で均一に溶
解せしめ、そこへ(B)成分を添加し、均一に混合した
。これに(D)成分を順次加えてゆき、混合撹拌して予
備エマルションとした。(1) Precautions (2) Preparation method Component (C) was uniformly dissolved in component (A) at room temperature or with salt, and component (B) was added thereto and mixed uniformly. Component (D) was successively added thereto and mixed and stirred to form a preliminary emulsion.
これを、マイクロフルイダイザ−(Microflui
dics社製)により、700 k g/cm”、3Q
℃にて微細化しく比較例1.2を除(3)特性
第1表に示す如く、比較例1〜15に対して、本発明の
微細化エマルションである実施例1〜8は、皮膚安全性
試験、官能特性評価、保存安定性試験の全てに亘って、
良好なる評価が得られた。This is carried out using a microfluidizer (Microfluidizer).
(manufactured by DICS), 700 kg/cm”, 3Q
(3) Characteristics As shown in Table 1, Examples 1 to 8, which are micronized emulsions of the present invention, are finer than Comparative Examples 1 to 15. In all aspects of sex testing, sensory evaluation, and storage stability testing,
Good evaluations were obtained.
特に、ビタ藁ンEあるいはビタミンE誘導体を少量加え
ることにより、微細化エマルションの保存安定性が著し
く向上することが明らかに認められた。In particular, it was clearly observed that the storage stability of the micronized emulsion was significantly improved by adding a small amount of Vita Straw E or a vitamin E derivative.
以上記載の如く、本発明の微細化エマルション組成物は
、皮膚安全性が高く、官能特性に優れており、また保存
安定性にも優れていることが肥められた。As described above, the micronized emulsion composition of the present invention has been shown to have high skin safety, excellent sensory properties, and excellent storage stability.
Claims (1)
ン性界面活性剤の少なくとも一種、と (c)ビタミンE又はビタミンE誘導体の少なくとも一
種、と (d)水 を含有し、かつ前記(a):(b):(c)の重量比が
1:(0.5〜5.0):(0.01〜0.5)の範囲
である予備エマルション同士を衝突させる又は該予備エ
マルションを壁に衝突させることにより得られる、平均
粒径が10〜200nmであることを特徴とする微細化
エマルション組成物。[Scope of Claims] (a) at least one oily substance that is liquid at room temperature; (b) at least one nonionic surfactant having an HLB value in the range of 7.0 to 16.0; c) contains at least one kind of vitamin E or a vitamin E derivative and (d) water, and the weight ratio of (a):(b):(c) is 1:(0.5 to 5.0): (0.01 to 0.5) A fine emulsion characterized in that the average particle size is 10 to 200 nm, obtained by colliding preliminary emulsions with each other or colliding the preliminary emulsions with a wall. Composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31692589A JPH03178331A (en) | 1989-12-06 | 1989-12-06 | Microemulsion composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31692589A JPH03178331A (en) | 1989-12-06 | 1989-12-06 | Microemulsion composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03178331A true JPH03178331A (en) | 1991-08-02 |
Family
ID=18082449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31692589A Pending JPH03178331A (en) | 1989-12-06 | 1989-12-06 | Microemulsion composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03178331A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2745716A1 (en) * | 1996-03-07 | 1997-09-12 | Oreal | EMULSIONS OIL-IN-WATER FOAMING PRESSURISABLE ULTRAFINES |
| JP2001163726A (en) * | 1999-12-09 | 2001-06-19 | Pola Chem Ind Inc | Cosmetic |
| WO2001080989A1 (en) * | 2000-04-24 | 2001-11-01 | Sunstar Inc. | Transparent liquid composition |
| KR100335719B1 (en) * | 1997-04-09 | 2002-06-20 | 서경배 | A method for preparing Zinc pyrithion-containing suspension and Hair-care composition containing the same |
| JP2002241279A (en) * | 2001-02-16 | 2002-08-28 | Kanebo Ltd | Packaged product and adsorption prevention method |
| EP1243185A3 (en) * | 2001-03-22 | 2003-04-23 | Firmenich Sa | Transparent high oil loaded microemulsions |
| JP2003213005A (en) * | 2002-01-25 | 2003-07-30 | Shin Etsu Chem Co Ltd | Method for producing organopolysiloxane emulsion |
-
1989
- 1989-12-06 JP JP31692589A patent/JPH03178331A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2745716A1 (en) * | 1996-03-07 | 1997-09-12 | Oreal | EMULSIONS OIL-IN-WATER FOAMING PRESSURISABLE ULTRAFINES |
| EP0793955A3 (en) * | 1996-03-07 | 1998-03-11 | L'oreal | Pressurised dispensers comprising an ultrafine foaming o/w emulsion |
| KR100335719B1 (en) * | 1997-04-09 | 2002-06-20 | 서경배 | A method for preparing Zinc pyrithion-containing suspension and Hair-care composition containing the same |
| JP2001163726A (en) * | 1999-12-09 | 2001-06-19 | Pola Chem Ind Inc | Cosmetic |
| WO2001080989A1 (en) * | 2000-04-24 | 2001-11-01 | Sunstar Inc. | Transparent liquid composition |
| JP2002241279A (en) * | 2001-02-16 | 2002-08-28 | Kanebo Ltd | Packaged product and adsorption prevention method |
| EP1243185A3 (en) * | 2001-03-22 | 2003-04-23 | Firmenich Sa | Transparent high oil loaded microemulsions |
| JP2003213005A (en) * | 2002-01-25 | 2003-07-30 | Shin Etsu Chem Co Ltd | Method for producing organopolysiloxane emulsion |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60320380T2 (en) | COENZYM Q10 FORMULATIONS | |
| DE3586436T2 (en) | COSMETIC EMULSION AND METHOD FOR THE PRODUCTION THEREOF. | |
| CN1845720B (en) | Concentrated and diluted stable oil-in-water emulsion | |
| KR20150116655A (en) | Cosmetic composition stabilizing insoluble functional ingredient | |
| JP2912426B2 (en) | Micronized emulsion composition | |
| JPH03178331A (en) | Microemulsion composition | |
| KR102381622B1 (en) | Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax | |
| JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
| KR20190088026A (en) | Nano emulsion composition comprising nano-cellulose and producing method thereof | |
| EP1337227B1 (en) | Use of nanoparticulate wax in skin cosmetics | |
| JP2634444B2 (en) | Creamy or milky water-in-oil type emulsified cosmetic | |
| JPH0791173B2 (en) | Liposomes containing skin cosmetics | |
| EP1888219A1 (en) | Emulsifier composition based on pentaerythritol esters and alkoxylated nonionic emulsifiers | |
| KR0154366B1 (en) | Liquid crystal gel for stabilized oil soluble extracts of glyoyrrhizae radix and cosmetic compositions containing the same | |
| JP3308555B2 (en) | Method for producing finely divided emulsion composition | |
| KR20070080062A (en) | Stabilization technology using liposome technology of plant extract effective for acne suppression, cosmetic composition containing same and manufacturing method thereof | |
| EP0375082A2 (en) | Cosmetic composition | |
| JP2678138B2 (en) | O / W emulsion cosmetic composition containing milk | |
| JP3597520B2 (en) | External preparation for skin | |
| KR101221231B1 (en) | Transparent oil in water type emulsified cosmetic compositions | |
| JPH02169507A (en) | Cosmetic | |
| JPH03151316A (en) | Multiphase emulsion type cosmetics | |
| KR102889140B1 (en) | Method of production aromatic composition | |
| JPH0552810B2 (en) | ||
| JPS60166604A (en) | Preparation of weakly acidic w/o/w-type emulsion cosmetic |